Evidence map›Paper›PMID 32714180›Full record

ArticleFrontiers in aging neuroscience2020

Response: Commentary: Chronic PD-1 Checkpoint Blockade Does Not Affect Cognition or Promote Tau Clearance in a Tauopathy Mouse Model.

Yan Lin, Leslie A Sandusky-Beltran, Begona Gamallo-Lana, Adam Mar, Einar M Sigurdsson

Abstract readComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in aging neuroscience, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Unmasking a Paradox: Roles of the PD-1/PD-L1 Axis in Alzheimer's Disease-Associated Neuroinflammation.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2025
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Yan LinDepartment of Neuroscience and Physiology, Grossmann School of Medicine, Neuroscience Institute, New York University, New York, NY, United States.
Leslie A Sandusky-BeltranDepartment of Neuroscience and Physiology, Grossmann School of Medicine, Neuroscience Institute, New York University, New York, NY, United States.
Begona Gamallo-LanaDepartment of Neuroscience and Physiology, Grossmann School of Medicine, Neuroscience Institute, New York University, New York, NY, United States.
Adam MarDepartment of Neuroscience and Physiology, Grossmann School of Medicine, Neuroscience Institute, New York University, New York, NY, United States.
Einar M SigurdssonDepartment of Neuroscience and Physiology, Grossmann School of Medicine, Neuroscience Institute, New York University, New York, NY, United States.

Funding

Research Supplement to Promote Diversity in Health-Related ResearchR01AG032611 · NIA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI Einar M Sigurdsson · 2008 to 2026
$9.7M
Epitope-Specific Targeting of Tau Aggregates.R01NS077239 · NINDS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI Einar M Sigurdsson · 2011 to 2026
$7.9M
NIA NIH HHS R01 AG032611NINDS NIH HHS R01 NS077239
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Alzheimer's diseaseantibodybehaviormouse modelsPD-1 blockadetautauopathytherapy

Identifiers

PMID32714180
PMCPMC7351512

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.